BVX — Bivictrix Therapeutics Share News
0.000.00%
Last trade - 00:00- £6.19m
- £4.70m
REG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Last Day of Dealings
AnnouncementREG - BiVictriX Therapcts. - Positive In Vivo Data from BVX002 Programme
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Director Dealing
AnnouncementREG - BiVictriX Therapcts. - Result of General Meeting
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - TR-1: Notification of major holdings
AnnouncementREG - BiVictriX Therapcts. - Grant of Options
AnnouncementREG - BiVictriX Therapcts. - Proposed Voluntary Delisting
AnnouncementREG - BiVictriX Therapcts. - Interim Results
AnnouncementREG - BiVictriX Therapcts. - Result of Annual General Meeting
AnnouncementREG - BiVictriX Therapcts. - Publication of 2023 Annual Report & Notice of AGM
AnnouncementREG - BiVictriX Therapcts. - Compelling Safety Profile of BVX001
AnnouncementREG - BiVictriX Therapcts. - Innovate UK Grant Award to Accelerate ADC Pipeline
AnnouncementREG - BiVictriX Therapcts. - BiVictriX – Full Year Results 2023
AnnouncementREG - BiVictriX Therapcts. - Orphan Drug Designation & FDA INTERACT Meeting
AnnouncementREG - BiVictriX Therapcts. - Grant of Options – PDMR/Director Dealings
Announcement